Jain Global’s Regenxbio RGNX Stock Holding History

Jain Global’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-42,268	Closed	-$302K	–	1553
2025 Q1	$302K	Buy	+42,268	New	+$314K	﹤0.01%	681

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jain Global's RGNX Position: Q2 2025 in Review

Jain Global sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 42,268 shares — an estimated $302K sold.

Jain Global first reported a position in RGNX in Q1 2025 and held it in 1 quarter. The position peaked at $302K in Q1 2025. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

Jain Global reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
Jain Global sold 42,268 Regenxbio shares in Q2 2025, an estimated $302K.
Jain Global first reported a position in Regenxbio in Q1 2025 and held it in 1 quarter.
Jain Global's Regenxbio position peaked at $302K in Q1 2025.
159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Jain Global's 13F filing for Q2 2025, filed 14 Aug 2025.